GlassScriptPhysician profile
Angela P Cherlin
NPI 1508890567
$4,242.97
in general payments reported to CMS, 2019-2025
15 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,219 · 2020: $1,047 · 2021: $1,227 · 2022: $250 · 2024: $250 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,187.86 | 2019-2025 | Vemlidy |
| Astrazeneca Pharmaceuticals LP | $564.08 | 2019-2021 | |
| Glaxosmithkline, LLC. | $432.53 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $312.04 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $297.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $296.13 | 2019-2021 | |
| Amgen INC. | $241.90 | 2019-2021 | |
| Novo Nordisk INC | $222.68 | 2021 | |
| Amarin Pharma, INC. | $190.54 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $125.00 | 2022 | |
| Radius Health, INC. | $121.60 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $90.15 | 2019-2021 | |
| Lilly USA, LLC | $76.02 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $51.61 | 2020-2021 | |
| Abbvie INC. | $33.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Cherlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.